-The Telegraph New Delhi: The Supreme Court today asked the Centre to allow clinical trials on new pharmaceutical compounds only after ensuring to the extent possible that their potential benefits outweigh their risks and they are needed in India. A bench of Justices R.M. Lodha and Kurien Joseph, responding to a public interest petition by a non-government organisation called Swasthya Adhikar Manch, also told the Centre to ensure that the candidate compounds...
More »SEARCH RESULT
Total Matching Records found : 169
Funds dry up for drug discovery project -Rema Nagarajan
-The Times of India Funding for one of the foremost drug discovery projects in India came to an end on Monday as the financial year closed because the ministry of science and technology did not clear the cabinet note meant to extend funding for the project on time. The Open Source Drug Discovery (OSDD) project of the Council of Scientific and Industrial Research (CSIR), meant to discover drugs for neglected diseases, had...
More »Ayurveda Offers Balm to Cancer Patients -KS Harikrishnan
-IPS News THIRUVANANTHAPURAM: Balakrishnan, a labourer from Kochi in the southern Indian state of Kerala, was suffering from oral cancer. He was admitted to the Regional Cancer Centre (RCC) in Thiruvananthapuram. After the first course of radiation therapy, the 60-year-old could not eat or drink because of severe pain and infection in the mouth. An Ayurvedic mouth wash developed from the Neem plant was administered to Balakrishnan for three weeks during the...
More »Video-recording of consent for clinical trials driving away subjects, SC told -Dhananjay Mahapatra
-The Times of India NEW DELHI: The new draft protocol for clinical trials of drugs, on the lines suggested by the Supreme Court, is making it difficult for global drug manufacturers to find subjects for testing new chemical compositions. The protocol has made it mandatory for companies intending to conduct human trials of drugs to video-record the free consent of patients to be part of the trial. It also mandates them to...
More »Questions about India’s drug industry-Narayan Lakshman
-The Hindu Unless a deeper, institutional change is ushered in to break the nexus between drug companies and the regulatory regime, Indians consuming drugs may be exposing themselves to serious risks Even before I walked into the Mayflower Hotel in the heart of Washington on a crisp autumn afternoon to meet Dinesh Thakur, whistle-blower and former director of India-based pharmaceutical giant Ranbaxy, I had a hunch that this conversation would spark some...
More »
